ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Autoimmune Diseases May Have Features of both Autoimmune and Autoinflammatory Diseases

by Renée Bacher • November 10, 2019

  • Tweet
  • Email
Print-Friendly Version
© Liya Graphics / shutterstock.com

© Liya Graphics / shutterstock.com

The field of autoimmunity is evolving to include a whole new set of conditions called autoinflammatory diseases, some of which include sensorineural deafness among their symptoms, according to new research by Andrea Vambutas, MD, chair of otolaryngology at Long Island Jewish Medical Center and North Shore University Medical Center in New York.

You Might Also Like

  • AAO-HNS14: Treatments Beyond Steroids for Sudden Sensorineural Hearing Loss Examined
  • Cellular Therapy of Autoimmune Disease
  • Are Steroids the Best Treatment for AIED?
  • Tonsillectomy, Adenoidectomy Tied to Higher Risks of Respiratory, Allergic, Infectious Diseases
Explore This Issue
November 2019

Dr. Vambutas, an active clinician and professor of otolaryngology and molecular medicine at the Zucker School of Medicine at Hofstra/Northwell, is also an investigator in the Center for Autoimmune, Musculoskeletal, and Hematopoietic Diseases at the Feinstein Institutes for Medical Research. She delivered the Howard P. House Memorial Lecture for Advances in Otology on September 17, 2019 at the American Academy of Otolaryngology–Head and Neck Surgery Annual Meeting on key biologic and clinical features that distinguish autoimmune from autoinflammatory disease and covered new treatment possibilities in the pipeline for sensorineural deafness.

Autoimmune and allergic disorders are on the rise. According to Dr. Vambutas’ presentation, these include more than 80 distinct diseases and affect 14 to 23 million people. When it comes to immune-mediated hearing loss—for example, in the case of Meniére’s disease, sudden sensorineural hearing loss (SSNHL), or autoimmune inner ear disease (AIED) —the challenge clinicians face is that there is no specific diagnostic biologic marker to show the severity of disease, how it should be treated, or for how long.

Autoimmune or Autoinflammatory?

Understanding autoimmune and autoinflammatory disease requires knowing the difference between the innate and the adaptive immune response. According to the presentation, when the innate immune system works, the macrophages come in first and present antigen to the adaptive immune response. Autoinflammatory disease occurs when the innate immune response isn’t working. Autoimmune disease occurs when the adaptive immune response isn’t working.

The triggers for these rare diseases are largely unknown but may include genetic predisposition, allergy, or even acoustic trauma. Although autoinflammatory diseases are genetic, no genetic marker for AIED has been identified, and patients do not typically have afflicted relatives. The clinical treatment history for patients with these conditions has been limited to prednisone; methotrexate and TNF antagonists have limited efficacy. Of the 60% of patients who initially respond to steroid treatment, only 14% remain responsive after 34 months, and those patients are at risk for side effects that can range from osteoporosis to psychosis. Steroid-resistant patients have been limited to rehabilitative strategies such as hearing aids and cochlear implants, because no medical therapy has been shown to be effective.

Pages: 1 2 3 | Single Page

Filed Under: Features Tagged With: AAO-HNS 2019, AIED, autoimmune inner ear disease, autoimmunity, inner earIssue: November 2019

You Might Also Like:

  • AAO-HNS14: Treatments Beyond Steroids for Sudden Sensorineural Hearing Loss Examined
  • Cellular Therapy of Autoimmune Disease
  • Are Steroids the Best Treatment for AIED?
  • Tonsillectomy, Adenoidectomy Tied to Higher Risks of Respiratory, Allergic, Infectious Diseases

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.